1. Survival After Surgery for Pathologic Stage IA Non-Small Cell Lung Cancer Associated With Idiopathic Pulmonary Fibrosis 
Yuichi Saito, MD, Yasuyuki Kawai, MD, Nobumasa Takahashi, MD, PhD, Tomohiko Ikeya, MD, PhD, Katsumi Murai, MD, PhD, Yoshinori Kawabata, MD, PhD, Eishin Hoshi, MD, PhD 
The Annals of Thoracic Surgery 
Volume 92, Issue 5, Pages (November 2011)
DOI: /j.athoracsur
Copyright © Terms and Conditions

2. Fig 1
Overall 5-year survival in patients with pathologic stage IA non-small cell lung cancer was 54.2% for the 28 patients with idiopathic pulmonary fibrosis (IPF, dashed line) and 88.3% for the 322 patients without IPF (solid line). The median follow-up was 4.20 years for IPF patients and 4.95 years for non-IPF patients.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © Terms and Conditions

3. Fig 2
Overall 6-year survival in 28 patients, matched by propensity score, with pathologic stage IA non-small cell lung cancer was 54.2% in the patients with idiopathic pulmonary fibrosis (IPF; dashed line) and 82.6% for the patients without IPF (solid line). The median follow-up was 4.20 years for IPF patients and 4.15 years for non-IPF patients group.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © Terms and Conditions